共查询到20条相似文献，搜索用时 31 毫秒
1.
Alison L Van Eenennaam 《畜牧与生物技术杂志(英文版)》2014,(1):1-14
In 2012, genetically engineered （GE） crops were grown by 17.3 million farmers on over 170 million hectares. Over 70% of harvested GE biomass is fed to food producing animals, making them the major consumers of GE crops for the past 15 plus years. Prior to commercialization, GE crops go through an extensive regulatory evaluation. Over one hundred regulatory submissions have shown compositional equivalence, and comparable levels of safety, between GE crops and their conventional counterparts. One component of regulatory compliance is whole GE food/feed animal feeding studies. Both regulatory studies and independent peer-reviewed studies have shown that GE crops can be safely used in animal feed, and rDNA fragments have never been detected in products （e.g. milk, meat, eggs） derived from animals that consumed GE feed. Despite the fact that the scientific weight of evidence from these hundreds of studies have not revealed unique risks associated with GE feed, some groups are calling for more animal feeding studies, including long-term rodent studies and studies in target livestock species for the approval of GE crops. It is an opportune time to review the results of such studies as have been done to date to evaluate the value of the additional information obtained. Requiring long-term and target animal feeding studies would sharply increase regulatory compliance costs and prolong the regulatory process associated with the commercialization of GE crops. Such costs may impede the development of feed crops with enhanced nutritional characteristics and durability, particularly in the local varieties in small and poor developing countries. More generally it is time for regulatory evaluations to more explicitly consider both the reasonable and unique risks and benefits associated with the use of both GE plants and animals in agricultural systems, and weigh them against those associated with existing systems, and those of regulatory inaction. This would represent a shift away from a GE evaluation process that currently focuses only on risk assessment and identifying ever diminishing marginal hazards, to a regulatory approach that more objectively evaluates and communicates the likely impact of approving a new GE plant or animal on agricultural production systems. 相似文献
2.
The commercial use of animal cloning for breeding food producing animals has been limited so far by biological and technical constraints such as adverse effects on the health and welfare of animals, especially high perinatal and postnatal disease and mortality of clones. However, the improvement of the technique may overcome those problems in future and contribute to the spread of cloning in agricultural production, which raises concern not only on health and welfare aspects but also on food safety and ethics. This may cause conflict in international trade. The present article reviews these topics on the basis of up-to-date scientific opinions. 相似文献
3.
Alison L Van Eenennaam 《畜牧与生物技术杂志(英文版)》2013,4(1):37
In 2012, genetically engineered (GE) crops were grown by 17.3 million farmers on over 170 million hectares. Over 70% of harvested GE biomass is fed to food producing animals, making them the major consumers of GE crops for the past 15 plus years. Prior to commercialization, GE crops go through an extensive regulatory evaluation. Over one hundred regulatory submissions have shown compositional equivalence, and comparable levels of safety, between GE crops and their conventional counterparts. One component of regulatory compliance is whole GE food/feed animal feeding studies. Both regulatory studies and independent peer-reviewed studies have shown that GE crops can be safely used in animal feed, and rDNA fragments have never been detected in products (e.g. milk, meat, eggs) derived from animals that consumed GE feed. Despite the fact that the scientific weight of evidence from these hundreds of studies have not revealed unique risks associated with GE feed, some groups are calling for more animal feeding studies, including long-term rodent studies and studies in target livestock species for the approval of GE crops. It is an opportune time to review the results of such studies as have been done to date to evaluate the value of the additional information obtained. Requiring long-term and target animal feeding studies would sharply increase regulatory compliance costs and prolong the regulatory process associated with the commercialization of GE crops. Such costs may impede the development of feed crops with enhanced nutritional characteristics and durability, particularly in the local varieties in small and poor developing countries. More generally it is time for regulatory evaluations to more explicitly consider both the reasonable and unique risks and benefits associated with the use of both GE plants and animals in agricultural systems, and weigh them against those associated with existing systems, and those of regulatory inaction. This would represent a shift away from a GE evaluation process that currently focuses only on risk assessment and identifying ever diminishing marginal hazards, to a regulatory approach that more objectively evaluates and communicates the likely impact of approving a new GE plant or animal on agricultural production systems. 相似文献
4.
New sophisticated laboratory techniques, as well as established interactions between basic science, researchers and veterinarians, have led to an exponential increase in our understanding of the animal body in health and disease. The advent of animal cloning, the identification and characterization of stem cells, and publication of the various mammalian genomes has afforded the opportunity to exploit these technologies to better understand disease and develop new therapies. In human medicine, these medical advances are already being translated into clinical practice, the promise being that previously untreatable or incurable chronic diseases will become a thing of the past. In parallel, the veterinary profession is looking to these technologies to explore novel therapies for chronic diseases, such as osteoarthritis in companion animals, and is applying these technologies to enhance food animal production. This review focuses on the emerging area of stem cell biology and explores the potential applications of stem cell technologies to veterinary medicine. 相似文献
5.
Fehlhaber K 《DTW. Deutsche tier?rztliche Wochenschrift》2003,110(8):312-315
Microorganisms by far are representing the most important cause for food safety risks. Sources of food contamination are given along the whole food chain. The most frequent causative agents of food infections, Salmonella and Campylobacter, mostly can be found in the animals herds. A real improvement of the situation can only be reached by a strong inclusion of the agricultural area in the programs for repressing the pathogens. Problems in animal health and premortal stress of the slaughter animals cause considerable bacterial translocation processes and increase the consumer risks. Only few publications exist on the influence of the animal farming systems on the development of microbial food risks. The consumer accepts only animal management systems, which meet the demands for animal welfare, economical efficiency and especially the demand for product safety. 相似文献
6.
Rodriguez-Martinez H 《Reproduction in domestic animals》2012,47(Z1):21-26
Commercialization of animal biotechnologies, including those related to reproduction [also known as assisted reproductive techniques (ARTS)], is an increasing reality in developing countries, following the enormous flow of information around us and the increasing global commercial interests in areas where cattle production has its major assets. The present review discusses the achievements of various biotechnological tools for reproduction in cattle including semen handling for artificial insemination (AI), superovulation and embryo transfer (MOET), in vitro handling of oocytes and production of embryos, reproductive cloning and emerging technologies (sex selection, gene targeting and nuclear transfer for livestock transgenesis, genomics for marker-assisted selection, etc.). The application of these technologies for cattle breeding is critically discussed in relation to their impact in the improvement of the efficiency of dairy and beef production in developed and - particularly - in developing countries, which ultimately rule the possibilities of a competitive and sound production of food for human consumption. Despite the remarkable progress made and the punctual importance of some of the above-mentioned technologies, AI remains the most important assisted reproductive technology (ART) in developing countries. Any attempt to gain widespread of any other ART under the predominant economical conditions in developing countries ought to match the simplicity and the success of AI as a breeding tool. 相似文献
7.
The animal health pharmaceutical industry has proactively reported on the volumes of member company antimicrobial active ingredients sold in the U.S. At the individual company level, reporting of finished product distribution data to the FDA is a regulatory requirement, with applications to surveillance and pharmacovigilance. An accounting of product manufactured is done for purposes of good business practices, as well as marketing analyses. Additional applications of antimicrobial usage data might include use in risk assessments, such as for the FDA's Center for Veterinary Medicine Guidance for Industry #152 for the evaluation of the microbiological safety of antimicrobials intended for use in food animals. Compilation of national usage data will be a complex undertaking, hindered by issues such as confidentiality, auditing, field use practice variations, population dynamics (e.g. disease incidence, market conditions for poultry and livestock production), and generic usage. The amounts or volumes in pounds should be considered relative to the large number of animals under husbandry in the United States. Large volumes might seem impressive unless put into proper context. Until such time as a clearly defined application of national usage data is agreed, it is recommended that local usage programs will provide more useful information to perpetuate prudent antimicrobial use in animals. 相似文献
8.
An algorithm was developed as a tool to rapidly assess the potential for a new or emerging disease of livestock to adversely affect humans via consumption or handling of meat product, so that the risks and uncertainties can be understood and appropriate risk management and communication implemented. An algorithm describing the sequence of events from occurrence of the disease in livestock, release of the causative agent from an infected animal, contamination of fresh meat and then possible adverse effects in humans following meat handling and consumption was created. A list of questions complements the algorithm to help the assessors address the issues of concern at each step of the decision pathway. The algorithm was refined and validated through consultation with a panel of experts and a review group of animal health and food safety policy advisors via five case studies of potential emerging diseases of cattle. Tasks for model validation included describing the path taken in the algorithm and stating an outcome. Twenty-nine per cent of the 62 experts commented on the model, and one-third of those responding also completed the tasks required for model validation. The feedback from the panel of experts and the review group was used to further develop the tool and remove redundancies and ambiguities. There was agreement in the pathways and assessments for diseases in which the causative agent was well understood (for example, bovine pneumonia due to Mycoplasma bovis). The stated pathways and assessments of other diseases (for example, bovine Johne's disease) were not as consistent. The framework helps to promote objectivity by requiring questions to be answered sequentially and providing the opportunity to record consensus or differences of opinion. Areas for discussion and future investigation are highlighted by the points of diversion on the pathway taken by different assessors. 相似文献
9.
10.
The paper discusses central moral issues raised by the applications of advanced biotechnology to animal agriculture and introduces the major ethical concepts and principles of animal bioethics. It is argued that biotechnology enables human beings to transform animals according to human needs, which blurs the boundary between humans and non-human animals in moral and biological sense. The more humans change animals, the more responsible humans are for the welfare of the animals and the greater their moral obligations. The paper introduces the main ethical approaches to animal welfare, traces the philosophical roots of animal ethics in the Judeo-Christian tradition and discusses the views of classical and contemporary ethicists such as Kant, Bentham, Mill, Peter Singer and Tom Regan. The paper explores the concept of animal welfare, suffering and rights, and the values behind Animal Liberation. Special attention is given to the animal welfare issues posed by cloning, genetic engineering and patenting of living organism. For each technology, actual or potential risks to animal welfare are identified and their moral implications are outlined. It is noted that the traditional moral principles of animal welfare, animal interests and animal rights are inadequate as means for evaluating the morality of certain advanced technologies because the technologies can change the animals in profound ways that make animal awareness too limited to give rise to claims about welfare, interests or rights. The principle of animal integrity is endorsed as an alternative better suited for evaluating the morality of advanced biotechnology. 相似文献
11.
12.
ABSTRACT: Non-typhoidal Salmonella represents an important human and animal pathogen world-wide. Most human salmonellosis cases are foodborne, but each year infections are also acquired through direct or indirect animal contact in homes, veterinary clinics, zoological gardens, farm environments or other public, professional or private settings. Clinically affected animals may exhibit a higher prevalence of shedding than apparently healthy animals, but both can shed Salmonella over long periods of time. In addition, environmental contamination and indirect transmission through contaminated food and water may complicate control efforts. The public health risk varies by animal species, age group, husbandry practice and health status, and certain human subpopulations are at a heightened risk of infection due to biological or behavioral risk factors. Some serotypes such as Salmonella Dublin are adapted to individual host species, while others, for instance Salmonella Typhimurium, readily infect a broad range of host species, but the potential implications for human health are currently unclear. Basic hygiene practices and the implementation of scientifically based management strategies can efficiently mitigate the risks associated with animal contacts. However, the general public is frequently unaware of the specific disease risks involved, and high-risk behaviors are common. Here we describe the epidemiology and serotype distribution of Salmonella in a variety of host species. In addition, we review our current understanding of the public health risks associated with different types of contacts between humans and animals in public, professional or private settings, and, where appropriate, discuss potential risk mitigation strategies. 相似文献
13.
During the past century, reductions in animal diseases have resulted in a safer, more uniform, and more economical food supply. In the United States, the passage of the 1906 Federal Meat Inspection Act mandated better sanitary conditions for slaughter and processing, as well as inspection of live animals and their processed products. Following World War II, Congress passed the Poultry Products Inspection Act. Both acts are regulated by the Food Safety and Inspection Service (FSIS) of the US Department of Agriculture (USDA). The USDA's Animal and Plant Health Inspection Service (APHIS) is responsible for regulations governing the health of live animals prior to slaughter. This article is a brief overview of the ways in which the current predominance of zoonotics among emerging diseases underscores the importance of veterinary health professionals and the need for continued coordination between animal-health and public-health officials. Examples of intersections between animal- and public-health concerns include bovine spongiform encephalopathy (BSE) and Johne's disease, as well as extending beyond food safety to diseases such as avian influenza (AI). In the United States, we have in place an extensive public and private infrastructure to address animal-health issues, including the necessary expertise and resources to address animal-health emergencies. However, many challenges remain, including a critical shortage of food-animal veterinarians. These challenges can be met by recruiting and training a cadre of additional food-supply veterinarians, pursuing new technologies, collaborating with public-health officials to create solutions, and sending a clear and consistent message to the public about important animal-health issues. 相似文献
14.
Genetically engineered (GE) animals are likely to have an important role in the future in meeting the food demand of a burgeoning global population. There have already been many notable achievements using this technology in livestock, poultry and aquatic species. In particular, the use of RNA interference (RNAi) to produce virus‐resistant animals is a rapidly‐developing area of research. However, despite the promise of this technology, very few GE animals have been commercialised. This review aims to provide information so that veterinarians and animal health scientists are better able to participate in the debate on GE animals. 相似文献
15.
Epizootics in Industrial Livestock Production: Preventable Gaps in Biosecurity and Biocontainment 
下载免费PDF全文
下载免费PDF全文 J. H. Leibler K. Dalton A. Pekosz G. C. Gray E. K. Silbergeld 《Zoonoses and public health》2017,64(2):137-145
While technological advances in animal husbandry have facilitated increases in global meat production, the high density and geographic concentration of food animal production facilities pose risks of infectious disease transmission. The scale of the 2014–2015 highly pathogenic avian influenza H5N2 outbreak in the United States demonstrates the challenges in achieving pathogen control within and around industrial animal facilities using existing technologies. We discuss gaps in current practice in two specific systems within these facilities – ventilation and waste management – which are under‐recognized as important drivers of microbial porosity. The development of innovative ventilation systems to reduce influx and efflux of pathogens is critically needed, and cross‐sectoral partnerships should be incentivized to do so. Adapting current human biosolid treatment technologies for farm applications, reducing animal stocking density and shifting waste management responsibility from farmer to corporation would reduce risk from current manure management systems. While innovative approaches to functionally altering the industrial food animal production system remain important priorities to promote sustainability, our intention here is to identify gaps within the current system that allow for pathogen emergence and transmission and address specific areas in which technological, administrative or policy changes are necessary to mitigate these risks. 相似文献
16.
Hartung J 《DTW. Deutsche tier?rztliche Wochenschrift》2000,107(12):503-506
The modern consumer is increasingly concerned about the welfare of farm animals which are kept in intensive systems on specialised farms where the health and well-being is almost completely dependent on the will, ability and care of the farmer. Further demands related to animal production are consumer health (quality and safety of food products), the protection of the environment and cheap food. The currently used husbandry systems are man made and emphasise automation which requires permanent critical observation of the welfare of the animals. Ethological indicators are equally important as health and performance to evaluate keeping systems. Future animal farming will be influenced by new technologies such as electronic animal identification and milking robots, and more important by biotechnology and genome analysis. Veterinary surgeons and farmers have to co-operate on the basis of scientifically sound animal welfare schemes which help to protect our farm animals in modern and intensive livestock production systems. 相似文献
17.
Singer RS Cox LA Dickson JS Hurd HS Phillips I Miller GY 《Preventive veterinary medicine》2007,79(2-4):186-203
To achieve further reductions in foodborne illness levels in humans, effective pre-harvest interventions are needed. The health status of food animals that are destined to enter the human food supply chain may be an important, although often overlooked, factor in predicting the risk of human foodborne infections. The health status of food animals can potentially influence foodborne pathogen levels in three ways. First, diseased animals may shed higher levels of foodborne pathogens. Second, animals that require further handling in the processing plant to remove affected parts may lead to increased microbial contamination and cross-contamination. Finally, certain animal illnesses may lead to a higher probability of mistakes in the processing plant, such as gastrointestinal ruptures, which would lead to increased microbial contamination and cross-contamination. Consequently, interventions that reduce the incidence of food animal illnesses might also help reduce bacterial contamination on meat, thereby reducing human illness. Some of these interventions, however, might also present a risk to human health. For example, the use of antibiotics in food animals can reduce rates of animal illness but can also select for antibiotic-resistant bacteria which can threaten human treatment options. In this study, we present a mathematical model to evaluate human health risks from foodborne pathogens associated with changes in animal illness. The model is designed so that potential human health risks and benefits from interventions such as the continued use of antibiotics in animal agriculture can be evaluated simultaneously. We applied the model to a hypothetical example of Campylobacter from chicken. In general, the model suggests that very minor perturbations in microbial loads on meat products could have relatively large impacts on human health, and consequently, small improvements in food animal health might result in significant reductions in human illness. 相似文献
18.
Although the Food and Drug Administration has never sanctioned the extra-label use of drugs in animals, it has not, until recently, objected when veterinarians deviated from label instructions as long as such use did not result in violative residues in food products derived from treated animals. However, because of the potential human health hazards associated with abuse of this position, the FDA has developed a less lenient policy toward the extra-label use of drugs in food animals. A brief review of the legislated responsibility and authority of the FDA with particular reference to the extra-label use of drugs in food animals is provided. Emphasis is placed on how anesthetics and anesthesia adjuncts in food animals can pose human health hazards. 相似文献
19.
W M Knight 《Journal of animal science》1987,65(2):581-583
The Center for Veterinary Medicine of the Food and Drug Administration (FDA) is charged with implementing the Federal Food, Drug and Cosmetic Act as it pertains to animal drugs and food additives. Title 21 of the Code of Federal Register Part 500 contains the regulations promogulated by the FDA as it implements this Act. Investigational New Animal Drug (INAD) applications provide for the shipment of experimental drugs and provide for the establishment of reconditioning procedures so edible products from research animals may be used for food. The record-keeping requirements for holders of INAD and for researchers are described. Protocol development and importation of investigational new animal drugs are discussed. 相似文献
20.
饲料“禁抗”势在必行，行业如何应对？ 总被引：1，自引：1，他引：0
抗生素自问世以来,在防治动物疾病、促进畜禽健康生长,提高养殖效益方面发挥了重要作用。但随着抗生素的不规范使用甚至滥用,药物残留和动物源细菌耐药性等问题逐渐浮出水面,给动物源性食品安全和公共卫生安全带来风险隐患。对此,农业农村部发布公告,实施促生长类药物饲料添加剂退出行动(简称饲料"禁抗")。从长期发展来看,饲料"禁抗"对行业可持续发展有积极正向作用,但短期对饲料养殖行业会带来一定的冲击。饲料"禁抗"是提高动物源性食品安全和公共卫生安全水平,促进畜牧业持续健康发展的必然要求,无论是饲料企业,还是养殖场户,应以冷静积极的心态面对,积极找寻饲用抗生素减量替代方案,并加速推广应用,以助力养殖业绿色健康发展,满足人们对安全优质动物源性食品的需求。 相似文献